Choi, Yun-Ju
Kim, Byung-Kun
Chung, Pil-Wook
Lee, Mi Ji
Park, Jung-Wook
Chu, Min Kyung
Ahn, Jin-Young
Kim, Byung-Su
Song, Tae-Jin
Sohn, Jong-Hee
Oh, Kyungmi
Lee, Kwang-Soo
Kim, Soo-Kyoung
Park, Kwang-Yeol
Chung, Jae Myun
Moon, Heui-Soo
Chung, Chin-Sang
Cho, Soo-Jin
Funding for this research was provided by:
Korean Neurological Association (KNA-16-MI-09)
Article History
Received: 5 July 2018
Accepted: 24 August 2018
First Online: 3 September 2018
Ethics approval and consent to participate
: This study protocol was reviewed and approved by the ethic committee/internal review boards of each participating hospital (2016–396-I) and proceeded according to the Declaration of Helsinki and the Good Clinical Practice guidelines.
: YJC, BKK, PWC, MJL, JWP, JYA, BSK, TJS, JHS, KO, KSL, SKK, KYP, JMC, HSM, and CSC report no conflict of interest.MKC was involved as a site investigator for a multicenter trial sponsored by Eli Lilly, worked an advisory member for Teva, and received lecture honoraria from Allergan Korea and Yuyu Pharmaceutical Company.SJC was involved as a site investigator of multicenter trial sponsored by Otsuka Korea, Eli Lilly and Company, Korea BMS, and Parexel Korea Co., Ltd., and received research support from Hallym University Research Fund 2016 and Myungin Research Fund 2016.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.